173 related articles for article (PubMed ID: 12694753)
1. An association between NQO1 genetic polymorphism and risk of bladder cancer.
Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
[TBL] [Abstract][Full Text] [Related]
2. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
Mandal RK; Dubey S; Panda AK; Mittal RD
Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
6. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
[TBL] [Abstract][Full Text] [Related]
8. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
Wang XC; Wang J; Tao HH; Zhang C; Xu LF
Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
[TBL] [Abstract][Full Text] [Related]
10. CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
Choi JY; Lee KM; Cho SH; Kim SW; Choi HY; Lee SY; Im HJ; Yoon KJ; Choi H; Choi I; Hirvonen A; Hayes RB; Kang D
Pharmacogenetics; 2003 Jun; 13(6):349-55. PubMed ID: 12777965
[TBL] [Abstract][Full Text] [Related]
11. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
12. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
13. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
14. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
[TBL] [Abstract][Full Text] [Related]
15. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
16. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
[TBL] [Abstract][Full Text] [Related]
19. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.
Wiencke JK; Spitz MR; McMillan A; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):87-92. PubMed ID: 9037558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
